Moderna’s RSV Vaccine Approved by FDA

Source link :

The US Food and Drug Administration (FDA) approved mRESVIA (mRNA-1345, Moderna), a vaccine for respiratory syncytial virus (RSV). The mRNA vaccine is approved for adults aged 60 years or older to prevent lower respiratory tract disease caused by RSV. It is the third vaccine to be approved for RSV in the past year after Arexvy […]

Author : News Health

Publish date : 2024-06-03 23:02:18

Copyright for syndicated content belongs to the linked Source.